Objective: Kidney stones are a common medical condition that is increasing in prevalence worldwide. Approximately, ∼80% of urinary calculi are composed of calcium oxalate (CaOx). There is a growing interest toward identifying therapeutic compounds that can inhibit the formation of CaOx crystals. However, some chemicals (e.g., antibiotics and bacterial metabolites) may directly promote crystallization. Current knowledge is limited regarding crystal promoters and inhibitors. Thus, we have developed an in vitro gel-based diffusion model to screen for substances that directly influence CaOx crystal formation. Materials and Methods: We used double diffusion of sodium oxalate and calcium chloride-loaded paper disks along an agar medium to facilitate the controlled formation of monohydrate and dihydrate CaOx crystals. A third disk was used for the perpendicular diffusion of a test substance to assess its influence on CaOx crystal formation. Results: We confirmed that citrates and magnesium are effective inhibitors of CaOx crystals. We also demonstrated that 2 strains of uropathogenic Escherichia coli are able to promote crystal formation. While the other tested uropathogens and most antibiotics did not change crystal formation, ampicillin was able to reduce crystallization. Conclusion: We have developed an inexpensive and high-throughput model to evaluate substances that influence CaOx crystallization.

1.
Moe
OW
.
Kidney stones: pathophysiology and medical management
.
Lancet
.
2006 Jan
;
367
(
9507
):
333
44
. .
2.
Scales
CD
,
Smith
AC
,
Hanley
JM
,
Saigal
CS
.
Urologic diseases in America Project. Prevalence of kidney stones in the United States
.
Eur Urol
.
2012 Jul
;
62
(
1
):
160
5
.
3.
Singh
P
,
Enders
FT
,
Vaughan
LE
,
Bergstralh
EJ
,
Knoedler
JJ
,
Krambeck
AE
,
Stone composition among first-time symptomatic kidney stone formers in the community.
Mayo Clin Proc
.
2015
;
90
(
10
):
1356
65
.
4.
Nicar
MJ
,
Hill
K
,
Pak
CY
.
Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro
.
J Bone Miner Res
.
1987
;
2
(
3
):
215
20
. .
5.
Riley
JM
,
Kim
H
,
Averch
TD
,
Kim
HJ
.
Effect of magnesium on calcium and oxalate ion binding
.
J Endourol
.
2013 Dec
;
27
(
12
):
1487
92
. .
6.
Phillips
R
,
Hanchanale
VS
,
Myatt
A
,
Somani
B
,
Nabi
G
,
Biyani
CS
.
Citrate salts for preventing and treating calcium containing kidney stones in adults
.
Cochrane Database Syst Rev
.
2015
;
10
:
CD010057
. .
7.
Matlaga
BR
,
Shah
OD
,
Assimos
DG
.
Drug-induced urinary calculi
.
Rev Urol
.
2003
;
5
(
4
):
227
31
.
8.
Daudon
M
,
Frochot
V
,
Bazin
D
,
Jungers
P
.
Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment
.
Drugs
.
2018 Feb
;
78
(
2
):
163
201
. .
9.
Schwaderer
AL
,
Wolfe
AJ
.
The association between bacteria and urinary stones
.
Ann Transl Med
.
2017 Jan
;
5
(
2
):
32
. .
10.
Tavichakorntrakool
R
,
Prasongwattana
V
,
Sungkeeree
S
,
Saisud
P
,
Sribenjalux
P
,
Pimratana
C
,
Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis
.
Nephrol Dial Transplant
.
2012 Nov
;
27
(
11
):
4125
30
. .
11.
Barr-Beare
E
,
Saxena
V
,
Hilt
EE
,
Thomas-White
K
,
Schober
M
,
Li
B
,
The interaction between Enterobacteriaceae and calcium oxalate deposits
.
PLoS One
.
2015 Oct
;
10
(
10
):
e0139575
. .
12.
Grohe
B
,
Rogers
KA
,
Goldberg
HA
,
Hunter
GK
.
Crystallization kinetics of calcium oxalate hydrates studied by scanning confocal interference microscopy
.
J Cryst Growth
.
2006 Oct
;
295
(
2
):
148
57
. .
13.
Hennequin
C
,
Lalanne
V
,
Daudon
M
,
Lacour
B
,
Drueke
T
.
A new approach to studying inhibitors of calcium oxalate crystal growth
.
Urol Res
.
1993 Mar
;
21
(
2
):
101
8
. .
14.
Schneider
HJ
,
Bothor
W
,
Berg
W
,
Börner
RH
,
Jakob
M
.
A gel model for measuring crystallization inhibitor activities
.
Urol Int
.
1983
;
38
(
1
):
33
8
. .
15.
Cody
AM
,
Horner
HT
,
Cody
RD
.
SEM study of the fine surface features of synthetic calcium oxalate monohydrate crystals
.
Scan Electron Microsc
.
1982
;
1
:
185
97
.
16.
Bolte
S
,
Cordelières
FP
.
A guided tour into subcellular colocalization analysis in light microscopy
.
J Microsc
.
2006 Dec
;
224
:
213
32
. .
17.
Rasband
W
.
ImageJ
.
Bethesda, Maryland, USA
:
U. S. National Institutes of Health
;
1997
. Available from: https://imagej.nih.gov/ij/.
18.
Peng
T
,
Thorn
K
,
Schroeder
T
,
Wang
L
,
Theis
FJ
,
Marr
C
,
A BaSiC tool for background and shading correction of optical microscopy images
.
Nat Commun
.
2017 Jun
;
8
(
1
):
14836
7
. .
19.
Forster
B
,
Van De Ville
D
,
Berent
J
,
Sage
D
,
Unser
M
.
Complex wavelets for extended depth-of-field: a new method for the fusion of multichannel microscopy images
.
Microsc Res Tech
.
2004 Sep
;
65
(
1–2
):
33
42
. .
20.
Preibisch
S
,
Saalfeld
S
,
Tomancak
P
.
Globally optimal stitching of tiled 3D microscopic image acquisitions
.
Bioinformatics
.
2009 Jun
;
25
(
11
):
1463
5
. .
21.
Chan
BP
,
Vincent
K
,
Lajoie
GA
,
Goldberg
HA
,
Grohe
B
,
Hunter
GK
.
On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides
.
Colloids Surf B Biointerfaces
.
2012 Aug
;
96
:
22
8
. .
22.
Taller
A
,
Grohe
B
,
Rogers
KA
,
Goldberg
HA
,
Hunter
GK
.
Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals
.
Biophys J
.
2007 Sep
;
93
(
5
):
1768
77
. .
23.
Vaitheeswari
S
,
Sriram
R
,
Brindha
P
,
Kurian
GA
.
Studying inhibition of calcium oxalate stone formation: an in vitro approach for screening hydrogen sulfide and its metabolites
.
Int Braz J Urol
.
2015
;
41
(
3
):
503
10
. .
24.
Tasian
GE
,
Jemielita
T
,
Goldfarb
DS
,
Copelovitch
L
,
Gerber
JS
,
Wu
Q
,
Oral antibiotic exposure and kidney stone disease
.
J Am Soc Nephrol
.
2018
;
29
(
6
):
1731
40
. .
25.
El-Gamel
NEA
.
Metal chelates of ampicillin versus amoxicillin: synthesis, structural investigation, and biological studies
.
J Coord Chem
.
2010 Feb
;
63
(
3
):
534
43
. .
26.
Al
KF
,
Daisley
BA
,
Chanyi
RM
,
Bjazevic
J
,
Razvi
H
,
Reid
G
,
Oxalate-degrading Bacillus subtilis mitigates urolithiasis in a Drosophila melanogaster model
.
mSphere
.
2020 Oct
;
5
(
5
):
e00498
20
. .
27.
Knoop
KA
,
McDonald
KG
,
Kulkarni
DH
,
Newberry
RD
.
Antibiotics promote inflammation through the translocation of native commensal colonic bacteria
.
Gut
.
2016 Jul
;
65
(
7
):
1100
9
. .
28.
Thorsteinsson
SB
,
Bergan
T
,
Oddsdottir
S
,
Rohwedder
R
,
Holm
R
.
Crystalluria and ciprofloxacin, influence of urinary pH and hydration
.
Chemotherapy
.
1986
;
32
(
5
):
408
17
. .
29.
Siegel
WH
.
Unusual complication of therapy with sulfamethoxazole-trimethoprim
.
J Urol
.
1977 Mar
;
117
(
3
):
397
. .
30.
Kanlaya
R
,
Naruepantawart
O
,
Thongboonkerd
V
.
Flagellum is responsible for promoting effects of viable Escherichia coli on calcium oxalate crystallization, crystal growth, and crystal aggregation
.
Front Microbiol
.
2019 Nov
;
10
:
2507
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.